Thiamazole


Thông tin thuốc gốc
Chỉ định và Liều dùng
Oral
Adjunct to radio-iodine therapy, Graves' disease, Hyperthyroidism, Preparation for thyroidectomy
Adult: Initially, 15-60 mg daily in 3 divided doses, depending on the severity of the disease; gradually reduce to a maintenance dose of 5-15 mg daily once patient is euthyroid. Usual treatment duration: 6 months to 2 years (for conservative treatment of hyperthyroidism).
Child: Initially, 0.3-0.5 mg/kg daily in 3 divided doses. Maintenance: Approx 1/2 of the initial dose.
Cách dùng
Should be taken with food.
Chống chỉ định
Previous damage to bone marrow or other serious adverse effects associated with treatment of thiamazole or other thioamides (e.g. carbimazole, propylthiouracil).
Thận trọng
Patient with moderate to severe granulocytopenia, pre-existing cholestasis (not caused by hyperthyroidism). Hepatic and renal impairment. Children. Pregnancy (particularly during 1st trimester) and lactation.
Tác dụng không mong muốn
Significant: Bleeding, hypoprothrombinaemia, aplastic anaemia, thrombocytopenia, leucopenia, dermatologic reactions, drug fever, hypothyroidism, lupus-like syndrome, vasculitis resulting in severe complications, pancreatitis, hepatotoxicity including acute liver failure.
Cardiovascular disease: Periarteritis.
Blood and lymphatic system disorders: Lymphadenopathy.
Ear and labyrinth disorders: Vertigo.
Endocrine disorders: Insulin autoimmune syndrome.
Gastrointestinal disorders: Dysgeusia, ageusia, acute salivary gland swelling, nausea, vomiting, epigastric distress.
Hepatobiliary disorders: Hepatitis, jaundice.
Musculoskeletal and connective tissue disorders: Arthralgia, myalgia.
Nervous system disorders: Neuritis, paraesthesia, headache, drowsiness.
Renal and urinary disorders: Rarely, nephritis.
Skin and subcutaneous tissue disorders: Rash, pruritus, urticaria, alopecia, skin pigmentation.
Potentially Fatal: Agranulocytosis.
Chỉ số theo dõi
Perform CBC with differential prior to initiation of therapy, during febrile illness and at the onset of pharyngitis. Monitor thyroid-stimulating hormone (TSH), serum free T4 and total T3 levels; prothrombin time (during treatment particularly before surgical procedures), LFT (at baseline and if symptoms of liver injury occur), thyrotropin receptor antibodies (before discontinuing treatment in patients with Graves’ disease).
Quá liều
Symptoms: Epigastric pain, nausea, vomiting, headache, oedema, fever, joint pain, pruritus, aplastic anaemia, agranulocytosis; hepatitis, exfoliative dermatitis, nephrotic syndrome, neuropathies, CNS stimulation or depression may also occur. Management: Supportive treatment.
Tương tác
Concomitant use with β-blockers, cardiac glycosides, oral anticoagulants (e.g. warfarin) and theophylline may require dosage adjustments according to changes in patient’s thyroid status.
Tác dụng
Description:
Mechanism of Action: Thiamazole inhibits the production of thyroid hormones by blocking the oxidation of iodine and its ability to combine with tyrosine to form thyroxine (T4) and triiodothyronine (T3).
Synonym: methimazole.
Onset: 12-18 hours.
Duration: 36-72 hours.
Pharmacokinetics:
Absorption: Readily and almost completely absorbed from the gastrointestinal tract. Bioavailability: Approx 93%. Time to peak plasma concentration: 1-2 hours.
Distribution: Accumulates in the thyroid gland. Readily crosses the placenta and enters breast milk.
Metabolism: Metabolised in the liver.
Excretion: Mainly via urine; faeces (minimal). Elimination half-life: 5-13 hours.
Đặc tính

Chemical Structure Image
Thiamazole

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 1349907, Methimazole. https://pubchem.ncbi.nlm.nih.gov/compound/Methimazole. Accessed Oct. 28, 2020.

Bảo quản
Store below 30°C.
Phân loại MIMS
Thuốc kháng giáp
Phân loại ATC
H03BB02 - thiamazole ; Belongs to the class of sulfur-containing imidazole derivative agents. Used in the management of thyroid diseases.
Tài liệu tham khảo
Anon. Methimazole. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 07/10/2020.

Anon. Methimazole. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 05/10/2020.

Buckingham R (ed). Thiamazole. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 05/10/2020.

Methimazole Tablet (ECI Pharmaceuticals, LLC). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 05/10/2020.

Methimazole Tablets, USP (PAR Pharmaceutical Companies, Inc.). U.S. FDA. https://www.fda.gov/. Accessed 05/10/2020.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Thiamazole từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2024 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
  • Kuptapazol
  • Metizol
  • Thyrozol
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Đăng nhập
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Đăng nhập